Abstract
Histoplasma capsulatum is a thermally dimorphic fungus that causes respiratory and systemic disease in both immunocompromised and immunocompetent individuals. Mammalian body temperatures trigger differentiation of Histoplasma into pathogenic yeasts, which infect and survive within host phagocytes. A signaling histidine kinase and three transcription factors regulate the dimorphic switch and expression of the yeast-phase regulon. Factors uniquely produced by yeasts facilitate Histoplasma survival by concealing molecular signatures to prevent Histoplasma detection by phagocytes and by detoxifying antimicrobial defense molecules produced by phagocytes. The synthesis of α-linked cell wall glucan polysaccharides enables stealthy entry into phagocytes and the expression of an extracellular superoxide dismutase and an extracellular catalase that protect Histoplasma yeasts specifically from host-derived reactive oxygen. Once survival and intracellular residence is accomplished, Histoplasma synthesizes factors for nutrient acquisition in the nutrient-limited phagosome, including iron-scavenging siderophores and a ferric reductase. In addition, Histoplasma yeasts secrete several novel factors with undefined functions that are probably linked to pathogenesis by virtue of their pathogenic-phase-specific expression and their extracellular location, which enables them to act at the host–pathogen interface.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aderem A (2003) Phagocytosis and the inflammatory response. J Infect Dis 187:S340–S345
Ajello L (1971) Distribution of Histoplasma capsulatum in the United States. In: Ajello L, Chick EW, Furcolow MF (eds) Histoplasmosis. Charles C. Thomas, Springfield, pp. 103–22
Albuquerque PC, Nakayasu ES, Rodrigues ML, Frases S, Casadevall A, Zancope-Oliveira RM, Almeida IC, Nosanchuk JD (2008) Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes. Cell Microbiol 10:1695–1710
Allen HL, Deepe GS (2006) B cells and CD4 − CD8− T cells are key regulators of the severity of reactivation histoplasmosis. J Immunol 177:1763–1771
Allendoerfer R, Deepe GS (1998) Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 160:6072–6082
Baddley JW, Winthrop KL, Patkar NM, Delzell E, Beukelman T, Xie F, Chen L, Curtis JR (2011) Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis 17:1664–1669
Batanghari JW, Goldman WE (1997) Calcium dependence and binding in cultures of Histoplasma capsulatum. Infect Immun 65:5257–5261
Beck MR, DeKoster GT, Hambly DM, Gross ML, Cistola DP, Goldman WE (2008) Structural features responsible for the biological stability of Histoplasma’s virulence factor CBP. Biochemistry 47:4427–4438
Beck MR, DeKoster GT, Cistola DP, Goldman WE (2009) NMR structure of a fungal virulence factor reveals structural homology with mammalian saposin B. Mol Microbiol 72:344–353
Bohse ML, Woods JP (2005) Surface localization of the Yps3p protein of Histoplasma capsulatum. Eukaryot Cell 4:685–693
Bohse ML, Woods JP (2007a) Expression and interstrain variability of the YPS3 gene of Histoplasma capsulatum. Eukaryot Cell 6:609–615
Bohse ML, Woods JP (2007b) RNA interference-mediated silencing of the YPS3 gene of Histoplasma capsulatum reveals virulence defects. Infect Immun 75:2811–2817
Bullock WE, Wright SD (1987) Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med 165:195–210
Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE (2006) Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 42:822–825
Cooper KG, Woods JP (2009) Secreted dipeptidyl peptidase IV activity in the dimorphic fungal pathogen Histoplasma capsulatum. Infect Immun 77:2447–2454
Deepe GS Jr, Gibbons R, Brunner GD, Gomez FJ (1996) A protective domain of heat-shock protein 60 from Histoplasma capsulatum. J Infect Dis 174:828–834
Deepe GS, Gibbons R, Woodward E (1999) Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J Immunol 163:4985–4993
Drummond RA, Brown GD (2011) The role of Dectin-1 in the host defence against fungal infections. Curr Opin Microbiol 14:392–399
Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE (1969) An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 99(Suppl):1–132
Edwards JA, Alore EA, Rappleye CA (2011a) The yeast-phase virulence requirement for α-glucan synthase differs among Histoplasma capsulatum chemotypes. Eukaryot Cell 10:87–97
Edwards JA, Zemska O, Rappleye CA (2011b) Discovery of a role for Hsp82 in Histoplasma virulence through a quantitative screen for macrophage lethality. Infect Immun 79:3348–3357
Eissenberg LG, Goldman WE (1987) Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect Immun 55:29–34
Fleischmann J, Wu-Hsieh B, Howard DH (1990) The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-gamma. J Infect Dis 161:143–145
Garfoot AG, Zemska O, Rappleye CA (2013) Histoplasma capsulatum depends on de novo vitamin biosynthesis for intraphagosomal proliferation. Manuscript submitted
Gildea LA, Morris RE, Newman SL (2001) Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol 166:1049–1056
Gomez FJ, Allendoerfer R, Deepe GS (1995) Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun 63:2587–2595
Gomez FJ, Pilcher-Roberts R, Alborzi A, Newman SL (2008) Histoplasma capsulatum cyclophilin a mediates attachment to dendritic cell VLA-5. J Immunol 181:7106–7114
Goodridge HS, Wolf AJ, Underhill DM (2009) Beta-glucan recognition by the innate immune system. Immunol Rev 230:38–50
Guimarães AJ, Frases S, Gomez FJ, Zancopé-Oliveira RM, Nosanchuk JD (2009) Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect Immun 77:1357–1367
Hamilton AJ, Bartholomew MA, Figueroa J, Fenelon LE, Hay RJ (1990) Evidence that the M antigen of Histoplasma capsulatum var. capsulatum is a catalase which exhibits cross-reactivity with other dimorphic fungi. J Med Vet Mycol 28:479–485
Hilty J, Smulian AG, Newman SL (2008) The Histoplasma capsulatum vacuolar ATPase is required for iron homeostasis, intracellular replication in macrophages and virulence in a murine model of histoplasmosis. Mol Microbiol 70:127–139
Hilty J, George Smulian A, Newman SL (2011) Histoplasma capsulatum utilizes siderophores for intracellular iron acquisition in macrophages. Med Mycol 49:633–642
Holbrook ED, Edwards JA, Youseff BH, Rappleye CA (2011) Definition of the extracellular proteome of pathogenic-phase Histoplasma capsulatum. J Proteome Res 10:1929–1943
Holbrook ED, Smolnycki KA, Youseff BH, Rappleye CA (2013) Redundant catalases detoxify phagocyte reactive oxygen and facilitate Histoplasma capsulatum pathogenesis. Infect Immun 81(7):2334–2346
Howard DH, Rafie R, Tiwari A, Faull KF (2000) Hydroxamate siderophores of Histoplasma capsulatum. Infect Immun 68:2338–2343
Hwang L, Hocking-Murray D, Bahrami AK, Andersson M, Rine J, Sil A (2003) Identifying phase-specific genes in the fungal pathogen Histoplasma capsulatum using a genomic shotgun microarray. Mol Biol Cell 14:2314–2326
Hwang LH, Mayfield JA, Rine J, Sil A (2008) Histoplasma requires SID1, a member of an iron-regulated siderophore gene cluster, for host colonization. PLoS Pathog 4:e1000044
Hwang LH, Seth E, Gilmore SA, Sil A (2012) SRE1 regulates iron-dependent and-independent pathways in the fungal pathogen Histoplasma capsulatum. Eukaryot Cell 11:16–25
Inglis DO, Berkes CA, Murray DRH, Sil A (2010) Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages. Infect Immun 78:3871–3882
Jain VV, Evans T, Peterson MW (2006) Reactivation histoplasmosis after treatment with anti-tumor necrosis factor α in a patient from a nonendemic area. Respir Med 100:1291–1293
Keath EJ, Abidi FE (1994) Molecular cloning and sequence analysis of yps-3, a yeast-phase-specific gene in the dimorphic fungal pathogen Histoplasma capsulatum. Microbiology 140:759–767
Keath EJ, Painter AA, Kobayashi GS, Medoff G (1989) Variable expression of a yeast-phase-specific gene in Histoplasma capsulatum strains differing in thermotolerance and virulence. Infect Immun 57:1384–1390
Kügler S, Young B, Miller VL, Goldman WE (2000) Monitoring phase-specific gene expression in Histoplasma capsulatum with telomeric GFP fusion plasmids. Cell Microbiol 2:537–547
Kurita N, Brummer E, Yoshida S, Nishimura K, Miyaji M (1991a) Antifungal activity of murine polymorphonuclear neutrophils against Histoplasma capsulatum. J Med Vet Mycol 29:133–143
Kurita N, Terao K, Brummer E, Ito E, Nishimura K, Miyaji M (1991b) Resistance of Histoplasma capsulatum to killing by human neutrophils. Evasion of oxidative burst and lysosomal-fusion products. Mycopathologia 115:207–213
Lane TE, Wu-Hsieh BA, Howard DH (1991) Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun 59:2274–2278
Lane TE, Wu-Hsieh BA, Howard DH (1994) Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates. Infect Immun 62:1940–1945
Lin J-S, Huang J-H, Hung L-Y, Wu S-Y, Wu-Hsieh BA (2010) Distinct roles of complement receptor 3, Dectin-1, and sialic acids in murine macrophage interaction with Histoplasma yeast. J Leukoc Biol 88:95–106
Long KH, Gomez FJ, Morris RE, Newman SL (2003) Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J Immunol 170:487–494
Marion CL, Rappleye CA, Engle JT, Goldman WE (2006) An α-(1,4)-amylase is essential for α-(1,3)-glucan production and virulence in Histoplasma capsulatum. Mol Microbiol 62:970–983
McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS (2003) Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 278:36250–36256
McVeigh I, Morton K (1965) Nutritional studies of Histoplasma capsulatum. Mycopathol Mycol Appl 25:294–308
Medoff G, Sacco M, Maresca B, Schlessinger D, Painter A, Kobayashi GS, Carratu L (1986) Irreversible block of the mycelial-to-yeast phase transition of Histoplasma capsulatum. Science (New York) 231:476–479
Nakamura LT, Wu-Hsieh BA, Howard DH (1994) Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect Immun 62:680–684
Nemecek JC, Wüthrich M, Klein BS (2006) Global control of dimorphism and virulence in fungi. Science 312:583–588
Newman SL, Bucher C, Rhodes J, Bullock WE (1990) Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest 85:223–230
Newman SL, Gootee L, Brunner G, Deepe GS (1994) Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest 93:1422–1429
Newman SL, Gootee L, Stroobant V, van der Goot H, Boelaert JR (1995) Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine. Antimicrob Agents Chemother 39:1824–1829
Nguyen VQ, Sil A (2008) Temperature-induced switch to the pathogenic yeast form of Histoplasma capsulatum requires Ryp1, a conserved transcriptional regulator. Proc Natl Acad Sci USA 105:4880–4885
Nittler MP, Hocking-Murray D, Foo CK, Sil A (2005) Identification of Histoplasma capsulatum transcripts induced in response to reactive nitrogen species. Mol Biol Cell 16:4792–4813
Rappleye CA, Engle JT, Goldman WE (2004) RNA interference in Histoplasma capsulatum demonstrates a role for α-(1,3)-glucan in virulence. Mol Microbiol 53:153–165
Rappleye CA, Eissenberg LG, Goldman WE (2007) Histoplasma capsulatum α-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor. Proc Natl Acad Sci USA 104:1366–1370
Schaffner A, Davis CE, Schaffner T, Markert M, Douglas H, Braude AI (1986) In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. J Clin Invest 78:511–524
Schnur RA, Newman SL (1990) The respiratory burst response to Histoplasma capsulatum by human neutrophils. Evidence for intracellular trapping of superoxide anion. J Immunol 144:4765–4772
Sebghati TS, Engle JT, Goldman WE (2000) Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science (New York) 290:1368–1372
Sengeløv H, Kjeldsen L, Diamond MS, Springer TA, Borregaard N (1993) Subcellular localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils. J Clin Invest 92:1467–1476
Sorgi CA, Secatto A, Fontanari C, Turato WM, Belangér C, de Medeiros AI, Kashima S, Marleau S, Covas DT, Bozza PT, Faccioli LH (2009) Histoplasma capsulatum cell wall β-Glucan induces lipid body formation through CD18, TLR2, and dectin-1 receptors: correlation with leukotriene B4 generation and role in HIV-1 infection. J Immunol 182:4025–4035
Sullivan TD, Rooney PJ, Klein BS (2002) Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast. Eukaryot Cell 1:895–905
Timmerman MM, Woods JP (1999) Ferric reduction is a potential iron acquisition mechanism for Histoplasma capsulatum. Infect Immun 67:6403–6408
Timmerman MM, Woods JP (2001) Potential role for extracellular glutathione-dependent ferric reductase in utilization of environmental and host ferric compounds by Histoplasma capsulatum. Infect Immun 69:7671–7678
Videm V, Strand E (2004) Changes in neutrophil surface-receptor expression after stimulation with FMLP, endotoxin, interleukin-8 and activated complement compared to degranulation. Scand J Immunol 59:25–33
Weaver CH, Sheehan KC, Keath EJ (1996) Localization of a yeast-phase-specific gene product to the cell wall in Histoplasma capsulatum. Infect Immun 64:3048–3054
Webster RH, Sil A (2008) Conserved factors Ryp2 and Ryp3 control cell morphology and infectious spore formation in the fungal pathogen Histoplasma capsulatum. Proc Natl Acad Sci USA 105:14573–14578
Winters MS, Spellman DS, Chan Q, Gomez FJ, Hernandez M, Catron B, Smulian AG, Neubert TA, Deepe GS (2008) Histoplasma capsulatum proteome response to decreased iron availability. Proteome Sci 6:36
Wolf JE, Massof SE (1990) In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B. Infect Immun 58:1296–1300
Wolf JE, Kerchberger V, Kobayashi GS, Little JR (1987) Modulation of the macrophage oxidative burst by Histoplasma capsulatum. J Immunol 138:582–586
Wolf JE, Abegg AL, Travis SJ, Kobayashi GS, Little JR (1989) Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities. Infect Immun 57:513–519
Youseff BH, Rappleye CA (2012) RNAi-based gene silencing using a GFP sentinel system in Histoplasma capsulatum. In: Brand AC, MacCallum DM (eds) Host-fungus interactions. Methods and protocols, methods in molecular biology, vol 845. Humana Press, New York, pp 151–164. http://link.springer.com/protocol/10.1007/978-1-61779-539-8_10
Youseff BH, Dougherty JA, Rappleye CA (2009) Reverse genetics through random mutagenesis in Histoplasma capsulatum. BMC Microbiol 9:236
Youseff BH, Holbrook ED, Smolnycki KA, Rappleye CA (2012) Extracellular superoxide dismutase protects Histoplasma yeast cells from host-derived oxidative stress. PLoS Pathog 8:e1002713
Zancopé-Oliveira RM, Reiss E, Lott TJ, Mayer LW, Deepe GS (1999) Molecular cloning, characterization, and expression of the M Antigen of Histoplasma capsulatum. Infect Immun 67:1947–1953
Zarnowski R, Cooper KG, Brunold LS, Calaycay J, Woods JP (2008a) Histoplasma capsulatum secreted γ-glutamyltransferase reduces iron by generating an efficient ferric reductant. Mol Microbiol 70:352–368
Zarnowski R, Dobrzyn A, Ntambi JM, Woods JP (2008b) Ferrous, but not ferric, iron maintains homeostasis in Histoplasma capsulatum triacylglycerides. Curr Microbiol 57:153–157
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rappleye, C.A. (2014). 7 Molecular Mechanisms of Histoplasma Pathogenesis. In: Kurzai, O. (eds) Human Fungal Pathogens. The Mycota, vol 12. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39432-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-39432-4_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39431-7
Online ISBN: 978-3-642-39432-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)